Oruka Therapeutics, Inc. (ORKA)
64.59
+0.52
(+0.81%)
USD |
NASDAQ |
May 08, 16:00
64.57
-0.02
(-0.03%)
After-Hours: 20:00
Oruka Therapeutics Shareholders Equity (Quarterly) : 471.93M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Liminatus Pharma, Inc. | -9.815M |
| MapLight Therapeutics, Inc. | 458.37M |
| Kailera Therapeutics, Inc. | -- |
| Veracyte, Inc. | 1.344B |
| Insight Molecular Diagnostics, Inc. | -31.46M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 488.62M |
| Total Liabilities (Quarterly) | 16.69M |
| Debt to Equity Ratio | 0.0041 |
| Current Ratio | 22.37 |
| Net Debt Paydown Yield | -0.01% |